Home › Funds › Blue Owl Capital Holdings LP › CGEM

Blue Owl Capital Holdings LP position in CGEM

CULLINAN THERAPEUTICS INC · Health Care

Blue Owl Capital Holdings LP reported holding 1,399,899 shares of CGEM (CULLINAN THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$21.5M, representing 4.04% of its reported portfolio and ranking #8 among its reported holdings. Blue Owl Capital Holdings LP has disclosed CGEM holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)1.40M sh
Reported value held$21.49M
Portfolio Weight4.04%
First reportedQ4 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Blue Owl Capital Holdings LP's CGEM position evolved

Blue Owl Capital Holdings LP first disclosed a stake in CGEM in Q4 2023 at 3,419,842 shares (US$34.8M). The position peaked in Q1 2024 at 2,924,842 shares, worth US$49.8M. Across 12 filings, Blue Owl Capital Holdings LP increased the stake 3 time(s), trimmed it 8 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,399,899 shares valued at US$21.5M — a reduction of -139,865 shares quarter over quarter.. Notable position changes include a 30% trim in Q2 2024 (shares fell 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 3.42M $34.85M New
Q1 2024 2.92M $49.84M Reduce
Q2 2024 2.05M $35.74M Reduce
Q3 2024 2.01M $33.66M Reduce
Q4 2024 2.37M $28.88M Add
Q1 2025 2.44M $18.44M Add
Q2 2025 2.39M $17.97M Reduce
Q3 2025 2.51M $14.89M Add
Q4 2025 2.35M $24.33M Reduce
Q1 2026 1.91M $27.14M Reduce
Q2 2026 1.54M $28.04M Reduce
Q3 2026 1.40M $21.49M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CGEM and 13F data

CGEM (CULLINAN THERAPEUTICS INC) is a Health Care company. 33 other funds we track also report a position in CGEM — the largest reported positions include MPM BioImpact LLC (US$177.2M), Lynx1 Capital Management LP (US$163.2M), BVF INC/IL (US$104.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CGEM

All CGEM fund holders →

FAQ

How long has Blue Owl Capital Holdings LP held CGEM?

Blue Owl Capital Holdings LP has disclosed CGEM holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is Blue Owl Capital Holdings LP's current position in CGEM?

As of Q3 2026, Blue Owl Capital Holdings LP holds 1.40M shares of CGEM (CULLINAN THERAPEUTICS INC), valued at $21.49M, representing 4.04% of its reported portfolio and ranking #8.

Has Blue Owl Capital Holdings LP been buying or selling CGEM?

In the latest 13F filing (Q3 2026), Blue Owl Capital Holdings LP reduced its position in CGEM. The position peaked in Q1 2024 at 2.92M shares.

Which other funds hold CGEM?

Other major institutional holders of CGEM include MPM BioImpact LLC, Lynx1 Capital Management LP, BVF INC/IL, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.